about
Motility of glioblastoma cells is driven by netrin-1 induced gain of stemnessNanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or AstrocytesOne-Pot Aqueous Synthesization of Near-Infrared Quantum Dots for Bioimaging and Photodynamic Therapy of Gliomas.Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma.The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.How to train glioma cells to die: molecular challenges in cell death.Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels.Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis.Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomasPatient-derived glioblastoma stem cells respond differentially to targeted therapies.Density-Dependent Regulation of Glioma Cell Proliferation and Invasion Mediated by miR-9.Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-β signaling.Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic compaMajor Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.How treatment monitoring is influencing treatment decisions in glioblastomas.Novel N-Substituted 2-(2-(Adamantan-1-yl)-1H-Indol-3-yl)-2-Oxoacetamide Derivatives: Synthesis and Biological Evaluation.Involvement of Intracellular Cholesterol in Temozolomide-Induced Glioblastoma Cell Death.Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma
P2860
Q30834482-5E8F56C1-0657-4232-A1CD-1128FDF3A4FFQ33627880-9367D55A-13A1-4EE1-B113-B7FE03378036Q36188526-66593FF1-419A-4DCF-AE45-3B2C1CCBFF91Q36259333-E2C4708C-45E7-4EA4-95FB-CF17A7D0DB6EQ37095230-40ECC9F0-A362-4FB8-95EA-AA225093C095Q38546470-9DBC278B-BA7A-4B29-BCF9-EB4A84DB6A86Q38626416-F7945270-E65C-4772-8C49-ADEE46B3CD78Q38702642-770C9A70-3994-4D2B-BFB3-B81DAF2EFEB2Q38811271-935DF511-EE5F-4A1F-87E0-04B2AC67874BQ38864999-6DD4CACE-23D7-4567-AB4B-53E5F7A6E841Q40178043-9FF56A2B-1BBA-499C-A0E8-8B368FC06D82Q41612669-21428C34-41DD-444A-9460-FE91CADB9D92Q42316508-C5640A37-5137-4ECD-8C45-3D6AF588A9EFQ42328087-626D5D03-97C0-40E2-8372-AA5B4D7AEFA2Q42433114-5ECB6132-B79F-4238-9AED-3E695AF9AED6Q47145292-0210ECAB-3A34-43DB-B9EA-3768C56915B5Q47773621-8BDD3100-787D-4333-ABED-93D93D36D052Q48292017-47CB894C-855B-4466-9AEA-40D62E829FABQ53102840-A627FC1F-AE19-4388-81F1-EE6F6B9C1ACAQ55456847-7DCF9395-FC3F-4B6C-8212-B8343D08D9BDQ57287856-A5D420E8-2FB7-4284-8E39-9235A7555FE0
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Current medical treatment of glioblastoma.
@ast
Current medical treatment of glioblastoma.
@en
Current medical treatment of glioblastoma.
@nl
type
label
Current medical treatment of glioblastoma.
@ast
Current medical treatment of glioblastoma.
@en
Current medical treatment of glioblastoma.
@nl
prefLabel
Current medical treatment of glioblastoma.
@ast
Current medical treatment of glioblastoma.
@en
Current medical treatment of glioblastoma.
@nl
P2093
P1476
Current medical treatment of glioblastoma.
@en
P2093
David M Peereboom
Manmeet S Ahluwalia
Vyshak Alva Venur
P304
P356
10.1007/978-3-319-12048-5_7
P577
2015-01-01T00:00:00Z